Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0000
0.0000
(0.00%)
At close: February 3 at 8:08:30 AM GMT+1
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RYI.BE | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Downgrade | Rodman & Renshaw: Buy to Neutral | 12/27/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 11/14/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 8/16/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 8/15/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/23/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 4/17/2024 |
Related Tickers
0M4.DU Mersana Therapeutics Inc
0.4706
-5.35%
8AW0.F Ocean Biomedical, Inc.
0.0860
-3.37%
8AW0.BE Ocean Biomedical Inc
0.0945
-2.07%
8AW0.MU Ocean Biomedical Inc
0.0965
-3.50%
0M4.SG Mersana Therapeutics Inc
0.4769
-1.22%
0S90.BE Syros Pharmaceuticals Inc
0.1380
-3.50%
0S90.MU Syros Pharmaceuticals Inc
0.1440
-5.88%
AT20.F Atara Biotherapeutics, Inc.
6.55
-5.76%
8AW0.SG Ocean Biomedical Inc
0.0915
+0.55%
NV4.F Cellectar Biosciences, Inc.
0.2800
+6.87%